Document/ExhibitDescriptionPagesSize
1: 10-Q Quarterly Report HTML 2.64M
2: EX-10.4 Material Contract HTML 1.02M
3: EX-10.5 Material Contract HTML 29K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 27K
13: R1 Cover HTML 78K
14: R2 Condensed Consolidated Statements of Operations HTML 155K
15: R3 Condensed Consolidated Statements of Comprehensive HTML 63K
Income (Loss)
16: R4 Condensed Consolidated Balance Sheets HTML 142K
17: R5 Condensed Consolidated Balance Sheets HTML 43K
(Parenthetical)
18: R6 Condensed Consolidated Statements of Stockholders' HTML 105K
Equity
19: R7 Condensed Consolidated Statements of Stockholders' HTML 28K
Equity (Parenthetical)
20: R8 Condensed Consolidated Statements of Cash Flows HTML 164K
21: R9 Basis of Presentation HTML 33K
22: R10 Significant Accounting Policies HTML 39K
23: R11 Revenues HTML 146K
24: R12 Acquisitions and Other Investments HTML 46K
25: R13 Accounts Receivable, Net HTML 115K
26: R14 Repurchases of Common Stock HTML 29K
27: R15 Earnings per Share HTML 47K
28: R16 Derivative Instruments HTML 61K
29: R17 Deposits HTML 47K
30: R18 Financing and Other Debt HTML 92K
31: R19 Off-Balance Sheet Arrangements HTML 36K
32: R20 Investment Securities HTML 181K
33: R21 Financial Instruments - Fair Value and HTML 104K
Concentrations of Credit Risk
34: R22 Redeemable Non-Controlling Interest HTML 31K
35: R23 Income Taxes HTML 33K
36: R24 Commitments and Contingencies HTML 31K
37: R25 Stock-Based Compensation HTML 30K
38: R26 Segment Information HTML 144K
39: R27 Supplementary Regulatory Capital Disclosure HTML 68K
40: R28 Subsequent Events HTML 30K
41: R29 Pay vs Performance Disclosure HTML 38K
42: R30 Insider Trading Arrangements HTML 32K
43: R31 Basis of Presentation (Policies) HTML 64K
44: R32 Revenues (Tables) HTML 143K
45: R33 Acquisitions and Other Investments (Tables) HTML 40K
46: R34 Accounts Receivable, Net (Tables) HTML 116K
47: R35 Earnings per Share (Tables) HTML 44K
48: R36 Derivative Instruments (Tables) HTML 61K
49: R37 Deposits (Tables) HTML 45K
50: R38 Financing and Other Debt (Tables) HTML 80K
51: R39 Investment Securities (Tables) HTML 184K
52: R40 Financial Instruments - Fair Value and HTML 94K
Concentrations of Credit Risk (Tables)
53: R41 Segment Information (Tables) HTML 139K
54: R42 Supplementary Regulatory Capital Disclosure HTML 64K
(Tables)
55: R43 Basis of Presentation (Details) HTML 27K
56: R44 Revenues - Summary of Disaggregation of Revenue HTML 76K
(Details)
57: R45 Revenues - Contract Assets and Liabilities From HTML 48K
Contracts with Customers (Details)
58: R46 Revenues - Narrative (Details) HTML 28K
59: R47 Revenues - Remaining Performance Obligation HTML 69K
(Details)
60: R48 Acquisitions and Other Investments - Narrative HTML 59K
(Details)
61: R49 Acquisitions and Other Investments - Schedule of HTML 67K
Recognized Identified Assets Acquired and
Liabilities Assumed (Details)
62: R50 Accounts Receivable, Net - Narrative (Details) HTML 30K
63: R51 Accounts Receivable, Net - Changes in Reserves for HTML 54K
Accounts Receivable (Details)
64: R52 Accounts Receivable, Net - Concentration of Credit HTML 35K
Risk (Details)
65: R53 Repurchases of Common Stock (Details) HTML 31K
66: R54 Earnings per Share (Details) HTML 52K
67: R55 Derivative Instruments - Narrative (Details) HTML 29K
68: R56 Derivative Instruments - Schedule of Interest Rate HTML 50K
Swaps (Details)
69: R57 Derivative Instruments - Location and Amounts of HTML 35K
Interest Rate Swap Gains and Losses (Details)
70: R58 Deposits (Details) HTML 50K
71: R59 Financing and Other Debt - Schedule of Short Term HTML 50K
Debt (Details)
72: R60 Financing and Other Debt - Schedule of Long Term HTML 92K
Debt (Details)
73: R61 Financing and Other Debt - Narrative (Details) HTML 127K
74: R62 Financing and Other Debt- Schedule of Total HTML 47K
Interest Expense for Convertible Note (Details)
75: R63 Off-Balance Sheet Arrangements (Details) HTML 54K
76: R64 Investment Securities - Narrative (Details) HTML 31K
77: R65 Investment Securities - Investment Securities HTML 96K
(Details)
78: R66 Investment Securities - Unrealized Losses On Debt HTML 66K
Securities (Details)
79: R67 Investment Securities - Maturity Dates Of HTML 53K
Available-For-Sale Securities (Details)
80: R68 Financial Instruments - Fair Value and HTML 98K
Concentrations of Credit Risk - Financial
Instruments Measured at Fair Value and Related
Hierarchy Levels (Details)
81: R69 Financial Instruments - Fair Value and HTML 42K
Concentrations of Credit Risk - Narrative
(Details)
82: R70 Financial Instruments - Fair Value and HTML 38K
Concentrations of Credit Risk - Contingent
Consideration Liability are Measured at Fair Value
on a Recurring Basis Using Unobservable Inputs
(Level 3) (Details)
83: R71 Financial Instruments - Fair Value and HTML 54K
Concentrations of Credit Risk - Schedule of Fair
Value of The Company's Financial Instruments
(Details)
84: R72 Redeemable Non-Controlling Interest (Details) HTML 52K
85: R73 Income Taxes (Details) HTML 47K
86: R74 Stock-Based Compensation (Details) HTML 28K
87: R75 Segment Information - Narrative (Details) HTML 30K
88: R76 Segment Information - Revenue by Segment (Details) HTML 65K
89: R77 Segment Information - Reconciliation of Adjusted HTML 71K
Operating Income to Income Before Income Taxes
(Details)
90: R78 Supplementary Regulatory Capital Disclosure HTML 77K
(Details)
91: R79 Subsequent Events (Details) HTML 33K
94: XML IDEA XML File -- Filing Summary XML 172K
92: XML XBRL Instance -- wex-20230930_htm XML 3.10M
93: EXCEL IDEA Workbook of Financial Report Info XLSX 181K
9: EX-101.CAL XBRL Calculations -- wex-20230930_cal XML 244K
10: EX-101.DEF XBRL Definitions -- wex-20230930_def XML 833K
11: EX-101.LAB XBRL Labels -- wex-20230930_lab XML 2.13M
12: EX-101.PRE XBRL Presentations -- wex-20230930_pre XML 1.29M
8: EX-101.SCH XBRL Schema -- wex-20230930 XSD 207K
95: JSON XBRL Instance as JSON Data -- MetaLinks 609± 907K
96: ZIP XBRL Zipped Folder -- 0001309108-23-000183-xbrl Zip 670K
The Company shall pay each non-employee board member the following annual cash retainer(s) based
upon his or her service. All payments hereunder shall be made in equal quarterly amounts.
Annual Chairman Cash Retainer
$
185,000
Annual Lead Director Cash Retainer
$
125,000
Annual Director Cash Retainer (other than Lead Director and Chairman)
$
85,000
Audit
Committee Chair Cash Retainer
$
30,000
Compensation Committee Chair Cash Retainer
$
25,000
Technology Committee Chair Cash Retainer
$
20,000
Finance Committee Chair Cash Retainer
$
20,000
Governance Committee Chair Cash Retainer
$
20,000
Equity
Retainers
All directors at the conclusion of the annual stockholders’ meeting (“ASM”) shall be granted a number of restricted stock units (“RSUs”) worth the equivalent of $200,000 at the then current stock price. Such RSUs will vest annually.
New Director Equity Grants
All new directors shall be granted a number of restricted stock units (“RSUs”) worth the equivalent of $100,000 at the then current stock price. Such RSUs are granted either (i) at the next annual stockholders’ meeting after a new non-employee director's appointment by the Board or (ii) upon initial election to the Board by our stockholders, whichever comes first, and will vest on the first anniversary of the date of grant
Fee Deferral
Directors
may defer all or part of their cash fees and equity retainers into deferred stock units which will be payable in Company shares to the Director only upon termination from Board Service.
Expense Reimbursement
Directors are reimbursed by the Company for their out-of-pocket travel and related expenses incurred in attending all Board and committee meetings.
Proration of Annual Cash Retainers for New Directors
To the extent a director is appointed at a time other than the ASM, any Annual Cash Retainers will be prorated.
